Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Matthew Strother

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2008
Lessons learned from development of docetaxelRobert Matthew Strother, Christopher Sweeney
Asia-Pacific Journal of Clinical Oncology|June 10, 2022
New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune-checkpoint inhibitorsAhmad Sufian Ab Rahman, Robert Matthew Strother, Johanna Paddison
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid TumorsElena Gabriela Chiorean, Patricia LoRusso, Robert Matthew Strother, et al.
Oncology|March 14, 2015
Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health ProblemMiriam O Laker-Oketta, Megan Wenger, Aggrey Semeere, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2008
Lessons learned from development of docetaxelRobert Matthew Strother, Christopher Sweeney
Asia-Pacific Journal of Clinical Oncology|June 10, 2022
New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune-checkpoint inhibitorsAhmad Sufian Ab Rahman, Robert Matthew Strother, Johanna Paddison
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid TumorsElena Gabriela Chiorean, Patricia LoRusso, Robert Matthew Strother, et al.
Oncology|March 14, 2015
Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health ProblemMiriam O Laker-Oketta, Megan Wenger, Aggrey Semeere, et al.
Pageof 1